Lucas Wong

1.6k total citations
50 papers, 1.3k citations indexed

About

Lucas Wong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lucas Wong has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Lucas Wong's work include Colorectal Cancer Treatments and Studies (15 papers), Genetic factors in colorectal cancer (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Lucas Wong is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Genetic factors in colorectal cancer (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Lucas Wong collaborates with scholars based in United States, Canada and China. Lucas Wong's co-authors include Lowell L. Hart, Yousif Abubakr, Allen Lee Cohn, Ramesh K. Ramanathan, Louis Fehrenbacher, Muhammad Wasif Saif, John D. Hainsworth, Barrett H. Childs, Lee S. Schwartzberg and Eric Hedrick and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Lucas Wong

46 papers receiving 1.2k citations

Peers

Lucas Wong

ONCOL

PRM

IMMUN

SURGE

Zhenhai Lu China

Man‐Hsin Hung Taiwan

Aparna Jayachandran Australia

Hao‐Wei Teng Taiwan

Nigel C. Bird United Kingdom

Anand S. Merchant United States

Hao‐Xiang Wu China

Kazunori Shibao Japan

Juan A. Recio Spain

Chen Huang China

Zhenhai Lu China

Lucas Wong

554 ×0.8

ONCOL

398 ×0.9

197 ×0.8

PRM

125 ×0.7

IMMUN

237 ×1.5

SURGE

Citations per year, relative to Lucas Wong Lucas Wong (= 1×) peers Zhenhai Lu

Countries citing papers authored by Lucas Wong

Since Specialization

Citations

This map shows the geographic impact of Lucas Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Wong more than expected).

Fields of papers citing papers by Lucas Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Wong. The network helps show where Lucas Wong may publish in the future.

Co-authorship network of co-authors of Lucas Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Wong. A scholar is included among the top collaborators of Lucas Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Wong. Lucas Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reddy, Priyanka, et al.. (2025). Early onset gastric cancer: clinical and molecular insights into a rising epidemic among younger adults. Baylor University Medical Center Proceedings. 38(4). 388–396.

Bessudo, Alberto, Abdul Haseeb, James A. Reeves, et al.. (2024). Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer. Clinical Colorectal Cancer. 23(3). 285–294. 4 indexed citations

Kim, Richard D., Mustapha Tehfé, Petr Kavan, et al.. (2024). Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D. Clinical Colorectal Cancer. 23(2). 118–127.e6. 8 indexed citations

Chen, Eric X., Petr Kavan, Mustapha Tehfé, et al.. (2024). Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E. Clinical Colorectal Cancer. 23(2). 183–193. 2 indexed citations

Volz, Marcus, Kimberly Walker, Kendall Hammonds, et al.. (2023). Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer. Clinical and Translational Radiation Oncology. 42. 100667–100667. 2 indexed citations

Chen, Xin, Liang Sheng, Jiguang Ma, et al.. (2021). 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone provokes progression from chronic pancreatitis to pancreatic intraepithelial neoplasia. iScience. 25(1). 103647–103647. 3 indexed citations

Chaves, Jorge, Petr Kavan, Marwan Fakih, et al.. (2020). 493P Pembrolizumab (pembro) plus mFOLFOX7 or FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC): Updated results from KEYNOTE-651 cohorts B and D. Annals of Oncology. 31. S450–S450. 4 indexed citations

Shervani, Saira, et al.. (2018). Prognostic factors and hazard ratios in colorectal cancer patients over 80 years of age: a retrospective, 20-year, single institution review. Journal of Gastrointestinal Oncology. 9(2). 254–262. 4 indexed citations

Wong, Lucas, et al.. (2017). Bile Duct Lymphoma Disguised as Cholangiocarcinoma. Baylor University Medical Center Proceedings. 30(2). 190–191. 3 indexed citations

10.

Potkul, Ronald K., Joseph M. Unger, Robert B. Livingston, et al.. (2016). Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. npj Breast Cancer. 2(1). 16024–16024. 4 indexed citations

11.

Johnson, Christopher M., Victoria Huynh, Laura Hargrove, et al.. (2015). Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor–Dependent Signaling. American Journal Of Pathology. 186(1). 123–133. 57 indexed citations

12.

Wong, Lucas, et al.. (2012). Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells. Protein Engineering Design and Selection. 25(10). 561–570. 42 indexed citations

13.

Subramanian, S., Prajna Mishra, Malay Chatterjee, et al.. (2009). Caspase-mediated Cleavage of β-Catenin Precedes Drug-induced Apoptosis in Resistant Cancer Cells. Journal of Biological Chemistry. 284(20). 13577–13588. 28 indexed citations

14.

Mishra, Rajakishore, Manoj Kumar Barthwal, Gautam Sondarva, et al.. (2007). Glycogen Synthase Kinase-3β Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3. Journal of Biological Chemistry. 282(42). 30393–30405. 68 indexed citations

15.

Ng, T.Y., et al.. (2006). Ethnicity is a factor to be considered before dose planning in ovarian cancer patients to be treated with topotecan. International Journal of Gynecological Cancer. 16(1). 135–139. 4 indexed citations

16.

Herrington, John D., et al.. (2005). Tumor Lysis Syndrome After Bortezomib Therapy for Plasma Cell Leukemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(12). 1820–1825. 21 indexed citations

17.

Wong, Lucas, et al.. (2005). Toxin Conjugate Therapy of Cancer. Seminars in Oncology. 32(6). 591–595. 16 indexed citations

18.

Sharma, Chandan, Anamika Pradeep, Lucas Wong, Ajay Rana, & Basabi Rana. (2004). Peroxisome Proliferator-activated Receptor γ Activation Can Regulate β-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway. Journal of Biological Chemistry. 279(34). 35583–35594. 119 indexed citations

19.

Wong, Lucas, et al.. (2004). Expression of Vascular Endothelial Growth Factor and HER2/neu in Stage II Colon Cancer and Correlation with Survival. Clinical Colorectal Cancer. 4(4). 262–267. 40 indexed citations

20.

Herrington, Jon D., et al.. (2002). Recurrent Peripheral Arterial Thrombosis Induced by Cisplatin and Etoposide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1200–1204. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact